Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Clinical trial NCT00288041 · COMPLETED

Trial details

NCT number: NCT00288041
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ciliary Body and Choroid Melanoma, Medium/Large Size Extraocular Extension Melanoma Iris Melanoma Recurrent Intraocular Melanoma Recurrent Melanoma Stage IV Melanoma

Start date: 2005-10-01
Primary completion: 2007-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.